
1. Immunity. 2019 Feb 19;50(2):390-402.e10. doi: 10.1016/j.immuni.2019.01.002. Epub 
2019 Jan 29.

A Neutrophil Timer Coordinates Immune Defense and Vascular Protection.

Adrover JM(1), Del Fresno C(2), Crainiciuc G(1), Cuartero MI(3), Casanova-Acebes 
M(4), Weiss LA(5), Huerga-Encabo H(6), Silvestre-Roig C(7), Rossaint J(8), Cossío
I(1), Lechuga-Vieco AV(2), García-Prieto J(2), Gómez-Parrizas M(2), Quintana
JA(1), Ballesteros I(1), Martin-Salamanca S(1), Aroca-Crevillen A(1), Chong
SZ(9), Evrard M(9), Balabanian K(10), López J(11), Bidzhekov K(12), Bachelerie
F(10), Abad-Santos F(13), Muñoz-Calleja C(11), Zarbock A(8), Soehnlein O(7),
Weber C(14), Ng LG(9), Lopez-Rodriguez C(6), Sancho D(2), Moro MA(3), Ibáñez
B(15), Hidalgo A(16).

Author information: 
(1)Area of Developmental and Cell Biology, Centro Nacional de Investigaciones
Cardiovasculares Carlos III (CNIC), Madrid, Spain.
(2)Area of Myocardial Pathophysiology, Centro Nacional de Investigaciones
Cardiovasculares Carlos III (CNIC), Madrid, Spain.
(3)Unidad de Investigación Neurovascular, Department of Pharmacology, Faculty of 
Medicine, Universidad Complutense; Instituto de Investigación Hospital 12 de
Octubre (i+12), Madrid, Spain.
(4)Area of Developmental and Cell Biology, Centro Nacional de Investigaciones
Cardiovasculares Carlos III (CNIC), Madrid, Spain; Present address: Tisch Cancer 
Institute, Mount Sinai School of Medicine, New York City, New York, USA.
(5)Area of Developmental and Cell Biology, Centro Nacional de Investigaciones
Cardiovasculares Carlos III (CNIC), Madrid, Spain; Present address: Centro
Nacional de Biotecnología, Madrid, Spain.
(6)Immunology Unit, Department of Experimental and Health Sciences, Pompeu Fabra 
University, Barcelona.
(7)Institute for Cardiovascular Prevention (IPEK),
Ludwig-Maximillians-Universität München; German Centre for Cardiovascular
Research (DZHK), partner site Munich Heart Alliance, Munich, Germany.
(8)Department of Anesthesiology, Intensive Care, and Pain Medicine, University of
Münster, Germany.
(9)Singapore Immunology Network (SIgN), Agency for Science, Technology and
Research (A(∗)STAR), Biopolis, Singapore.
(10)Inserm Unité Mixte de Recherche (UMR) S996, Université Paris-Sud, Laboratory 
of Excellence in Research on Medication and Innovative Therapeutics, Clamart,
France.
(11)Department of Immunology, Instituto de Investigación Sanitaria Princesa,
Hospital Universitario de La Princesa, Madrid, Spain.
(12)Institute for Cardiovascular Prevention (IPEK),
Ludwig-Maximillians-Universität München.
(13)Department of Clinical Pharmacology, Instituto Teófilo Hernando, Hospital
Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa,
Madrid, Spain.
(14)Institute for Cardiovascular Prevention (IPEK),
Ludwig-Maximillians-Universität München; Department of Biochemistry,
Cardiovascular Research Institute Maastricht (CARIM), Maastricht University,
Maastricht, the Netherlands.
(15)Area of Myocardial Pathophysiology, Centro Nacional de Investigaciones
Cardiovasculares Carlos III (CNIC), Madrid, Spain; CIBER de Enfermedades
Cardiovasculares (CIBERCV), Madrid, Spain; Department of Cardiology, Instituto de
Investigación Sanitaria (IIS)-Fundación Jiménez Díaz, Madrid, Spain.
(16)Area of Developmental and Cell Biology, Centro Nacional de Investigaciones
Cardiovasculares Carlos III (CNIC), Madrid, Spain; Institute for Cardiovascular
Prevention (IPEK), Ludwig-Maximillians-Universität München. Electronic address:
ahidalgo@cnic.es.

Erratum in
    Immunity. 2019 Nov 19;51(5):966-967.

Comment in
    Immunity. 2019 Feb 19;50(2):273-275.

Neutrophils eliminate pathogens efficiently but can inflict severe damage to the 
host if they over-activate within blood vessels. It is unclear how immunity
solves the dilemma of mounting an efficient anti-microbial defense while
preserving vascular health. Here, we identify a neutrophil-intrinsic program that
enabled both. The gene Bmal1 regulated expression of the chemokine CXCL2 to
induce chemokine receptor CXCR2-dependent diurnal changes in the transcriptional 
and migratory properties of circulating neutrophils. These diurnal alterations,
referred to as neutrophil aging, were antagonized by CXCR4 (C-X-C chemokine
receptor type 4) and regulated the outer topology of neutrophils to favor
homeostatic egress from blood vessels at night, resulting in boosted
anti-microbial activity in tissues. Mice engineered for constitutive neutrophil
aging became resistant to infection, but the persistence of intravascular aged
neutrophils predisposed them to thrombo-inflammation and death. Thus, diurnal
compartmentalization of neutrophils, driven by an internal timer, coordinates
immune defense and vascular protection.

Copyright © 2019 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.immuni.2019.01.002 
PMID: 30709741  [Indexed for MEDLINE]

